Figure 2
Figure 2. Effect of TLR inhibitors and ligands and addition of RNase. (A, B) pDCs were stimulated with HL5B either alone or together with IRS661, IRS869 (each 0.5μM), or R848 (1 μg/mL) as indicated. Relative expression of IFNα and TNFα mRNA normalized to β-actin. All values represent mean ± SD of 5 independent experiments. *P < .05; **P < .005 for HL5B versus HL5B plus inhibitor or activator, respectively. (C) Human pDCs were stimulated with HL5B (100 ng/mL) or a combination of HL5B and R848 (1 μg/mL) either alone or in the presence of RNase (10 μg/mL). RNAse was added 30 minutes before the other stimuli. Quantitative RT-PCR was performed after different periods of time, for up to 6 hours. Relative expression of TLR7 (left) or IFNα (right) was normalized to β-actin. Values represent mean ± SD of at least 5 independent experiments. *P < .01, **P < .005 for HL5B versus HL5B plus RNase.

Effect of TLR inhibitors and ligands and addition of RNase. (A, B) pDCs were stimulated with HL5B either alone or together with IRS661, IRS869 (each 0.5μM), or R848 (1 μg/mL) as indicated. Relative expression of IFNα and TNFα mRNA normalized to β-actin. All values represent mean ± SD of 5 independent experiments. *P < .05; **P < .005 for HL5B versus HL5B plus inhibitor or activator, respectively. (C) Human pDCs were stimulated with HL5B (100 ng/mL) or a combination of HL5B and R848 (1 μg/mL) either alone or in the presence of RNase (10 μg/mL). RNAse was added 30 minutes before the other stimuli. Quantitative RT-PCR was performed after different periods of time, for up to 6 hours. Relative expression of TLR7 (left) or IFNα (right) was normalized to β-actin. Values represent mean ± SD of at least 5 independent experiments. *P < .01, **P < .005 for HL5B versus HL5B plus RNase.

Close Modal

or Create an Account

Close Modal
Close Modal